HELIUS MEDICAL TECHNOLOGIES Files 8-K

Ticker: HSDT · Form: 8-K · Filed: May 6, 2024 · CIK: 1610853

Helius Medical Technologies, Inc. 8-K Filing Summary
FieldDetail
CompanyHelius Medical Technologies, Inc. (HSDT)
Form Type8-K
Filed DateMay 6, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001, $1,206.53, $4,500, $3,075.53
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, financials

TL;DR

HELIUS MEDICAL TECHNOLOGIES filed an 8-K, likely with financial updates.

AI Summary

On May 6, 2024, HELIUS MEDICAL TECHNOLOGIES, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific financial figures or new material events were detailed in the provided excerpt.

Why It Matters

This 8-K filing signals that HELIUS MEDICAL TECHNOLOGIES, INC. is providing updates to the SEC, which could include important operational or financial information relevant to investors.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure (8-K) without immediate indication of significant negative events.

Key Players & Entities

  • HELIUS MEDICAL TECHNOLOGIES, INC. (company) — Registrant
  • 0001558370-24-006700 (filing_id) — Accession Number
  • May 6, 2024 (date) — Filing Date
  • Delaware (jurisdiction) — State of Incorporation
  • 36-4787690 (tax_id) — IRS Employer Identification No.
  • 642 Newtown Yardley Road, Suite 100 (address) — Principal Executive Offices
  • Newtown, PA 18940 (address) — Principal Executive Offices

FAQ

What specific "Other Events" are being reported by HELIUS MEDICAL TECHNOLOGIES, INC. in this 8-K filing?

The provided excerpt of the 8-K filing does not detail the specific "Other Events" being reported, only that this item is included.

What is the significance of filing under "Financial Statements and Exhibits"?

Filing under "Financial Statements and Exhibits" typically means the company is providing updated financial information or including relevant documents as exhibits to the report.

When was HELIUS MEDICAL TECHNOLOGIES, INC. incorporated?

HELIUS MEDICAL TECHNOLOGIES, INC. was incorporated in Delaware, as indicated by the filing.

What is the principal executive office address for HELIUS MEDICAL TECHNOLOGIES, INC.?

The principal executive offices are located at 642 Newtown Yardley Road, Suite 100, Newtown, PA 18940.

What is the SEC file number for HELIUS MEDICAL TECHNOLOGIES, INC.?

The SEC file number for HELIUS MEDICAL TECHNOLOGIES, INC. is 001-38445.

Filing Stats: 532 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-05-06 09:05:23

Key Financial Figures

  • $0.001 — hich registered Class A Common Stock, $0.001 par value HSDT The Nasdaq Stock Mar
  • $1,206.53 — ock unit), resulting in a capped fee of $1,206.53. For the PoNS Mouthpiece (HCPCS code A4
  • $4,500 — based pricing on the cash pay price of $4,500, resulting in a total capped payment of
  • $3,075.53 — resulting in a total capped payment of $3,075.53. The full text of the press release iss

Filing Documents

01 Other Events

Item 8.01 Other Events. On May 6, 2024, Helius Medical Technologies, Inc. (the "Company") announced that the Centers for Medicare and Medicaid Services ("CMS") published a proposed fee schedule payment rates for the PoNS Controller and PoNS Mouthpiece to be discussed at CMS' bi-annual Healthcare Common Procedure Coding System ("HCPCS") public meeting to be held on May 29, 2024. For the PoNS Controller (HCPCS Code A4593), CMS preliminarily set pricing by mapping reimbursement to existing code E0745, (Neuromuscular stimulator, electronic shock unit), resulting in a capped fee of $1,206.53. For the PoNS Mouthpiece (HCPCS code A4594), CMS based pricing on the cash pay price of $4,500, resulting in a total capped payment of $3,075.53. The full text of the press release issued in conjunction with the announcement is included in Exhibit 99.1 to this Current Report on Form 8-K.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by Helius Medical Technologies, Inc. on May 6, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HELIUS MEDICAL TECHNOLOGIES, INC. Dated: May 6, 2024 By: /s/ Jeffrey S. Mathiesen Jeffrey S. Mathiesen Chief Financial Officer, Treasurer and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.